OpenAlex
PricingAboutJobs
Log inGet started
Work

ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome

HTML

Year: 2012
Type: article
Study design: Observational Study
Source: Leukemia
DOI: 10.1038/leu.2012.262
Authors: S Schnittger, C Eder, S Jeromin, T Alpermann, A Fasan, V Grossmann, A Kohlmann, T Illig, N Klopp, H-E Wichmann, K-A Kreuzer, C Schmid, P Staib, R Peceny, N Schmitz, W Kern, C Haferlach, T Haferlach
Institutions: Munich Leukemia Laboratory (Germany), Helmholtz Munich, Medizinische Hochschule Hannover, University of Cologne, University Hospital Augsburg, Sankt-Antonius-Hospital Eschweiler, Klinikum Osnabrück, Asklepios Klinik St. Georg
Language: English

Topic: Acute Myeloid Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: ASXL1 mutation, acute myeloid leukemia, prognostic factors, trisomy 8, RUNX1 mutation, NPM1 mutation, FLT3-ITD, FLT3-TKD, DNMT3A mutation, overall survival, event-free survival, myelodysplastic syndrome, immunophenotype
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2073358532
FWCI: 13.4
Cites: 57
Cited by: 244
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms